{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T17:50:36Z","timestamp":1786125036748,"version":"build-2736575974"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2019,4,16]],"date-time":"2019-04-16T00:00:00Z","timestamp":1555372800000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Neurosurg.","NEUROS"],"published-print":{"date-parts":[[2020,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>BACKGROUND<\/jats:title>\n                    <jats:p>Poor natural history of hemorrhagic Moyamoya disease (MMD) is related to high rehemorrhage rates between 32% and 61%. Postrevascularization, rehemorrhage rates reportedly decrease to 12% to 17%.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>OBJECTIVE<\/jats:title>\n                    <jats:p>To evaluate long-term functional outcomes and rehemorrhage rates of hemorrhagic MMD patients treated with surgical revascularization and examine these in relation to clinical and radiological factors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS<\/jats:title>\n                    <jats:p>Patients treated surgically for hemorrhagic MMD over a 26-yr period were identified. Modified Rankin scale (mRS) was used to assess clinical status at presentation and functional outcomes. Multivariable regression analyses were performed to evaluate the risk factors associated with rehemorrhage rates and functional outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>\n                      A total of 104 patients (mean age: 38.04 yr) were identified. The mean mRS score at baseline was 1.3. Of 172 revascularized hemispheres, 157 (91.3%) were direct superficial temporal artery (STA)-middle cerebral artery (MCA) bypasses and the rest indirect. Over the mean follow-up of 61.4 mo, 8 of 104 patients (7.7%) experienced rehemorrhage with rehemorrhage rate per person-years of 1.9%. A total of 4 patients died with 1 related to rehemorrhage. At the last follow-up, mean mRS score improved to 1.1. No significant risk factors were identified in relation to the rehemorrhage rates (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u00a0&lt;\u00a0.05). The patients\u2019 initial mRS score was positively associated with mRS scores at the final follow-up (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u00a0&lt;\u00a0.001). STA-MCA direct bypass was associated with better performance status (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u00a0=\u00a0.033).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION<\/jats:title>\n                    <jats:p>Rehemorrhage rate following surgical revascularization of the hemorrhagic MMD patients at 7.7% is lower compared with much higher natural history rates. Surgical revascularization improved patients' performance status. These outcomes support performing revascularization procedure with a preference for direct STA-MCA bypasses.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/neuros\/nyz074","type":"journal-article","created":{"date-parts":[[2019,2,17]],"date-time":"2019-02-17T23:24:48Z","timestamp":1550445888000},"page":"257-265","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":22,"title":["Functional Outcomes After Revascularization Procedures in Patients With Hemorrhagic Moyamoya Disease"],"prefix":"10.1227","volume":"86","author":[{"given":"Kumar","family":"Abhinav","sequence":"first","affiliation":[{"name":"Department of Neurosurgery and Stanford Stroke Center, Stanford University School of Medicine, Stanford, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil V","family":"Furtado","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery and Stanford Stroke Center, Stanford University School of Medicine, Stanford, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Troels H","family":"Nielsen","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery and Stanford Stroke Center, Stanford University School of Medicine, Stanford, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditya","family":"Iyer","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery and Stanford Stroke Center, Stanford University School of Medicine, Stanford, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A","family":"Gooderham","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery and Stanford Stroke Center, Stanford University School of Medicine, Stanford, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Teo","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery and Stanford Stroke Center, Stanford University School of Medicine, Stanford, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Lee","sequence":"additional","affiliation":[{"name":"Quantitative Sciences Unit, Department of Medicine, Stanford University School of Medicine, Stanford, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Summer S","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery and Stanford Stroke Center, Stanford University School of Medicine, Stanford, California"},{"name":"Quantitative Sciences Unit, Department of Medicine, Stanford University School of Medicine, Stanford, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary K","family":"Steinberg","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery and Stanford Stroke Center, Stanford University School of Medicine, Stanford, California"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,2]]},"reference":[{"issue":"5","key":"bib1-20240906","doi-asserted-by":"crossref","first-page":"927","DOI":"10.3171\/2009.4.JNS081649","article-title":"Clinical outcome after 450 revascularization procedures for moyamoya disease. Clinical article","volume":"111","author":"Guzman","year":"2009","journal-title":"J Neurosurg"},{"issue":"4","key":"bib2-20240906","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1159\/000345957","article-title":"Epidemiological and clinical features of moyamoya disease in the USA","volume":"40","author":"Kainth","year":"2013","journal-title":"Neuroepidemiology"},{"issue":"8","key":"bib3-20240906","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1136\/jnnp.2007.130666","article-title":"Novel epidemiological features of moyamoya disease","volume":"79","author":"Baba","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"bib4-20240906","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1161\/01.STR.0000221787.70503.ca","article-title":"Clinical features and outcome in North American adults with moyamoya phenomenon","volume":"37","author":"Hallemeier","year":"2006","journal-title":"Stroke"},{"issue":"6","key":"bib5-20240906","doi-asserted-by":"crossref","first-page":"976","DOI":"10.3171\/jns.2000.93.6.0976","article-title":"Long-term natural history of hemorrhagic type moyamoya disease in 42 patients","volume":"93","author":"Kobayashi","year":"2000","journal-title":"J Neurosurg"},{"issue":"5","key":"bib6-20240906","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.3171\/2014.7.JNS132434","article-title":"Outcome in adult patients with hemorrhagic moyamoya disease after combined extracranial-intracranial bypass","volume":"121","author":"Jiang","year":"2014","journal-title":"J Neurosurg"},{"issue":"3","key":"bib7-20240906","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1136\/jnnp-2012-302236","article-title":"Long term outcome after conservative and surgical treatment of haemorrhagic moyamoya disease","volume":"84","author":"Liu","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"bib8-20240906","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1161\/STROKEAHA.113.004386","article-title":"Effects of extracranial\u2013intracranial bypass for patients with hemorrhagic moyamoya disease","volume":"45","author":"Miyamoto","year":"2014","journal-title":"Stroke"},{"issue":"3","key":"bib9-20240906","doi-asserted-by":"crossref","first-page":"492","DOI":"10.3171\/2016.8.JNS152875","article-title":"Bypass surgery versus medical treatment for symptomatic moyamoya disease in adults","volume":"127","author":"Jang","year":"2017","journal-title":"J Neurosurg"},{"issue":"3","key":"bib10-20240906","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1001\/archneur.1969.00480090076012","article-title":"Cerebrovascular \u201cmoyamoya\u201d disease. Disease showing abnormal net-like vessels in base of brain","volume":"20","author":"Suzuki","year":"1969","journal-title":"Arch Neurol"},{"issue":"12","key":"bib11-20240906","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1161\/01.STR.28.12.2513","article-title":"A clinical comparison of definite moyamoya disease between South Korea and Japan","volume":"28","author":"Ikezaki","year":"1997","journal-title":"Stroke"},{"issue":"7","key":"bib12-20240906","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1161\/01.STR.29.7.1347","article-title":"Clinical features of moyamoya disease in the United States","volume":"29","author":"Chiu","year":"1998","journal-title":"Stroke"},{"issue":"Suppl 2","key":"bib13-20240906","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1016\/S0303-8467(97)00060-7","article-title":"Moyamoya disease in the United States","volume":"99","author":"Numaguchi","year":"1997","journal-title":"Clin Neurol Neurosurg"},{"issue":"8","key":"bib14-20240906","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1001\/archneur.58.8.1274","article-title":"Moyamoya: Indiana University Medical Center experience","volume":"58","author":"Yilmaz","year":"2001","journal-title":"Arch Neurol"},{"issue":"1","key":"bib15-20240906","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1161\/STROKEAHA.111.621300","article-title":"Moyamoya disease in China: its clinical features and outcomes","volume":"43","author":"Duan","year":"2012","journal-title":"Stroke"},{"issue":"1","key":"bib16-20240906","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jocn.2012.08.002","article-title":"The natural history of moyamoya in a North American adult cohort","volume":"20","author":"Gross","year":"2013","journal-title":"J Clin Neurosci"},{"issue":"5","key":"bib17-20240906","first-page":"1049","article-title":"High-risk age for rebleeding in patients with hemorrhagic moyamoya disease: long-term follow-up study","volume":"52","author":"Morioka","year":"2003","journal-title":"Neurosurgery"},{"issue":"1-2","key":"bib18-20240906","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jns.2013.02.010","article-title":"Quality of life and psychological impact in adult patients with hemorrhagic moyamoya disease who received no surgical revascularization","volume":"328","author":"Su","year":"2013","journal-title":"J Neurol Sci"},{"issue":"8","key":"bib19-20240906","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1161\/01.STR.27.8.1342","article-title":"Surgical therapy for adult moyamoya disease. Can surgical revascularization prevent the recurrence of intracerebral hemorrhage?","volume":"27","author":"Houkin","year":"1996","journal-title":"Stroke"},{"issue":"3","key":"bib20-20240906","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1161\/01.STR.29.3.625","article-title":"Effectiveness of superficial temporal artery-middle cerebral artery anastomosis in adult moyamoya disease: cerebral hemodynamics and clinical course in ischemic and hemorrhagic varieties","volume":"29","author":"Okada","year":"1998","journal-title":"Stroke"},{"issue":"2","key":"bib21-20240906","doi-asserted-by":"crossref","first-page":"E15","DOI":"10.3171\/FOC\/2008\/24\/2\/E15","article-title":"Long-term outcome of superficial temporal artery\u2013middle cerebral artery bypass for patients with moyamoya disease in the US","volume":"24","author":"Mesiwala","year":"2008","journal-title":"Neurosurg focus"},{"issue":"3","key":"bib22-20240906","doi-asserted-by":"crossref","first-page":"191","DOI":"10.7461\/jcen.2013.15.3.191","article-title":"Thirteen-year experience of 44 patients with adult hemorrhagic moyamoya disease from a single institution: clinical analysis by management modality","volume":"15","author":"Choi","year":"2013","journal-title":"J Cerebrovasc Endovasc Neurosurg"},{"issue":"Suppl 2","key":"bib23-20240906","doi-asserted-by":"crossref","first-page":"S194","DOI":"10.1016\/S0303-8467(97)00078-4","article-title":"The efficacy of bypass surgery for the patients with hemorrhagic moyamoya disease","volume":"99","author":"Fujii","year":"1997","journal-title":"Clin Neurol Neurosurg"},{"issue":"2","key":"bib24-20240906","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s00381-011-1535-5","article-title":"Hemorrhagic moyamoya disease in children: clinical features and surgical outcome","volume":"28","author":"Ahn","year":"2012","journal-title":"Childs Nerv Syst"},{"key":"bib25-20240906","article-title":"Impact of interethnic difference of collateral angioarchitectures on prevalence of hemorrhagic stroke in moyamoya disease","author":"Hori","journal-title":"Neurosurgery"},{"key":"bib26-20240906","doi-asserted-by":"crossref","first-page":"72","DOI":"10.4103\/2152-7806.97730","article-title":"Hemorrhage and risk of further hemorrhagic strokes following cerebral revascularization in moyamoya disease: a review of the literature","volume":"3","author":"Ryan","year":"2012","journal-title":"Surg Neurol Int"}],"container-title":["Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/neurosurgery\/advance-article-pdf\/doi\/10.1093\/neuros\/nyz074\/28439656\/nyz074.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/www.ovid.com\/10.1093\/neuros\/nyz074","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:49:17Z","timestamp":1786121357000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1093\/neuros\/nyz074"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,15]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1093\/neuros\/nyz074","relation":{},"ISSN":["0148-396X","1524-4040"],"issn-type":[{"value":"0148-396X","type":"print"},{"value":"1524-4040","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,15]]},"assertion":[{"value":"2018-06-19","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-02-14","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}